Methigic 8 Tablet

About Methigic 8 Tablet

Methigic 8 is a tablet containing 8 mg of methylprednisolone, made by Square Pharmaceuticals PLC. It belongs to the glucocorticoid class of medicines and is used for certain endocrine and rheumatic conditions.

There are 22 brands of Methyl Prednisolone listed in Bangladesh. The lowest listed price is Depodrol 2 mg Tablet at ৳ 3 per unit.

What is Methigic 8 Tablet?

Methigic 8 is an 8 mg tablet of methylprednisolone, a synthetic glucocorticoid. It is prescribed for selected endocrine disorders, such as primary or secondary adrenocortical insufficiency, congenital adrenal hyperplasia, nonsuppurative thyroiditis, and hypercalcemia linked to cancer. It is also used in certain rheumatic conditions, including rheumatoid arthritis, juvenile rheumatoid arthritis, ankylosing spondylitis, and various forms of bursitis and synovitis. Methylprednisolone works by reducing inflammation and suppressing immune activity. The doctor determines whether this medicine is suitable and how it should be taken.

Uses of Methigic 8

Methigic 8 is intended for endocrine disorders such as primary or secondary adrenocortical insufficiency, congenital adrenal hyperplasia, nonsuppurative thyroiditis, and hypercalcemia associated with cancer. It is also prescribed for rheumatic disorders including rheumatoid arthritis, juvenile rheumatoid arthritis, ankylosing spondylitis, acute and subacute bursitis, synovitis of osteoarthritis, and acute nonspecific tenosynovitis. Only a doctor can confirm whether it is appropriate for a particular patient.

How to use Methigic 8

Take Methigic 8 exactly as your doctor tells you. The doctor decides the dose, how often to take it, and how long the course should last. Swallow the tablet with water, following any instructions given by your prescriber. Do not change the dose or stop the medicine on your own, because glucocorticoids can need careful adjustment. If you forget a dose, ask your doctor or pharmacist what to do. Keep the medicine in a cool, dry place away from light and out of reach of children.

Side effects of Methigic 8

Short courses of methylprednisolone are often tolerated with few, mild side effects. Longer use or higher doses may cause more noticeable problems. Reported side effects include fluid retention, weight gain, high blood pressure, low potassium, headache, muscle weakness, and increased hair growth. Some effects can be serious with long-term use. Tell your doctor if you notice any unusual symptoms while taking Methigic 8.

Safety and precautions

Methigic 8 is pregnancy category C, meaning it should be used only if the potential benefit justifies the potential risk to the foetus. It has not been adequately evaluated in nursing mothers, so breastfeeding women should ask their doctor first. The medicine is contraindicated in systemic fungal infections and in people known to be hypersensitive to its components. Use it cautiously if you have hypothyroidism, cirrhosis, or ocular herpes simplex. Adrenocortical insufficiency may persist for months after stopping, so hormone therapy may be needed during stress. Always consult your doctor before starting or stopping this medicine.

Frequently asked questions

What does the 8 mg strength and tablet form mean?

Methigic 8 is supplied as a tablet, and each tablet contains 8 mg of methylprednisolone. The strength tells you how much of the active ingredient is in one tablet, but your doctor will decide how many tablets you need and for how long.

What is Methigic 8 used for and what kind of medicine is it?

Methigic 8 is a glucocorticoid, a type of corticosteroid medicine. It is used for certain endocrine disorders, such as adrenocortical insufficiency and congenital adrenal hyperplasia, and for rheumatic conditions like rheumatoid arthritis, ankylosing spondylitis, and bursitis. Your doctor will confirm if it is right for you.

Which medicines may interact with Methigic 8?

Methigic 8 may interact with erythromycin, clarithromycin, phenobarbital, phenytoin, rifampin, ketoconazole, estrogens including birth control pills, cyclosporin, and blood thinners such as warfarin. Because interactions can change how these medicines work, tell your doctor about all medicines you take.

Who should ask a doctor before using Methigic 8?

Ask your doctor first if you are pregnant, planning pregnancy, or breastfeeding. Also speak to your doctor if you have hypothyroidism, cirrhosis, ocular herpes simplex, a fungal infection, or a known allergy to any ingredient. Only a doctor can decide whether Methigic 8 is safe for you.

Indications

Endocrine Disorders: Primary or Secondary Adrenocortical Insufficiency, Congenital Adrenal Hyperplasia, Nonsuppurative Thyroiditis, Hypercalcemia associated with Cancer.

Rheumatic Disorders: Rheumatoid Arthritis. Juvenile Rheumatoid Arthritis, Ankylosing ... Read moreEndocrine Disorders: Primary or Secondary Adrenocortical Insufficiency, Congenital Adrenal Hyperplasia, Nonsuppurative Thyroiditis, Hypercalcemia associated with Cancer.

Rheumatic Disorders: Rheumatoid Arthritis. Juvenile Rheumatoid Arthritis, Ankylosing Spondylitis, Acute and Subacute Bursitis, Synovitis of Osteoarthritis, Acute nonspecific Tenosynovitis, Post-traumatic Osteoarthritis, Psoriatic Arthritis, Epicondylitis, Acute Gouty Arthritis.

Collagen Diseases: Systemic lupus Erythematosus, Systemic Dermatomyositis and Acute Rheumatic Carditis.

Dermatologic Diseases: Bullous Dermatitis Herpetiformis, Severe Erythema Multiforme (Stevens-Johnson syndrome), Severe Seborrheic Dermatitis, Exfoliative Dermatitis, Mycosis Fungoides, Pemphigus, Severe Psoriasis.

Allergy: Seasonal or Perennial Allergic Rhinitis, Drug hypersensitivity reactions, Serum Sickness, Contact Dermatitis, Bronchial Asthma and Atopic Dermatitis;

Ophthalmic Diseases: Allergic Corneal Ulcers, Herpes Zoster Ophthalmicus, Anterior segment inflammation, Sympathetic Ophthalmia, Keratitis, Optic Neuritis, Allergic Conjunctivitis, Chorioretinitis, iritis end iridocyclitis.

Respiratory Diseases: Symptomatic sarcoidosis, Loeffler's syndrome not manageable by other means, berylliosis, Aspiration Pneumonitis.

Hematological Disorders: Idiopathic Thrombocytopenic Purpura in adults, Secondary Thrombocytopenia in adults, Acquired (Autoimmune) Hemolytic Anemia, Erythroblastopenia, Congenital (Erythroid) Hypoplastic Anemia.

Neoplastic Diseases: For palliative management of Leukemias and Lymphomas in adults, Acute leukemia of childhood.

Edematous States: To induce a diuresis or remission of Proteinuria in the Nephrotic Syndrome, without Uremia, of the idiopathic type or that due to Lupus Erythematosus.

Gastrointestinal Disease: To tide the patient over a critical period of the disease in Ulcerative Colitis & Regional Enteritis.

CNS Disease: Acute Exacerbations of Multiple Sclerosis.

Pharmacology

Pharmacodynamic properties: Methylprednisolone Is a potent anti-inflammatory agent with the capacity to profoundly inhibit the immune system. Glucocorticoids primarily bind to and activate intracellular glucocorticoid receptors that being activated bind to promoter regions of DMA (which may activate or suppress transcription) and activate transcription factors that result in inactivation of genes through deacetylation of histones. Methylprednisolone influences the kidney and fluid & electrolyte balance, lipid,
protein, and carbohydrate metabolism, skeletal muscle, the cardiovascular system, the immune system, the nervous system, and the endocrine system.

Pharmacokinetic properties: The absolute bioavailability of Methylprednisclone is generally high (82% to 89%) following oral administration and rapidly absorbed and the maximum plasma concentration is achieved around 1.5 to 2.3 hours across doses following oral administration in normal healthy adults. Methylprednisolone is widely distributed into the tissues and its volume of distribution is 41-61.5 liter. It crosses the Wood-brain barrier and the placental barrier and is secreted in breast milk. The plasma protein binding of Methylprednisolone in humans is approximately 77%. Methylprednisolone is metabolized in the liver to inactive metabolites. No dosing adjustments are necessary for renal failure. Methylprednisolone is haemodializable.

Dosage & Administration

The usual range is 2-48 mg daily in divided doses, depending on the specific disease being treated. 

As anti-inflammatory or immunosuppressive initial dosage: As anti-inflammatory or immunosuppressive, the initial dosage of Methylprednisolone tablets may vary from 4-48 mg per day depending on the specific disease entity being treated, in situations of less severity lower doses will generally suffice while in selected patients higher initial doses may be required. The initial dosage should be maintained or adjusted until a satisfactory response is noted. If after a reasonable period of time there is a lack of satisfactory dirtied response, Methylprednisolone should be discontinued and the patient transferred to other appropriate therapy. It should be emphasized that dosage requirements are variable and must be Individualized on the basis of the disease under treatment and the response of the patient.

As anti-inflammatory or immunosuppressive maintenance dosage: After a favorable response is noted, the proper maintenance dosage should be determined by decreasing the initial drug dosage in small decrements at appropriate time intervals until the lowest dosage which will maintain an adequate clinical response is reached. It should be kept in mind that constant monitoring is needed in regard to drug dosage. If after long-term therapy the drug is to be stopped, it is recommended that it be withdrawn gradually rather than abruptly.

Multiple Sclerosis: In the treatment of acute exacerbations of multiple sclerosis, daily doses of 160 mg of Methylprednisolone for a week followed by 64 mg every other day for 1 month have been shown to be effective.

Methylprednisolone 4 mg tablet can be used to treat and to control severe allergy end dermatitis following the guideline listed below to minimize the steroid withdrawal syndromes:
  • Day 1: 2 tablets before breakfast + 1 tablet after lunch + 1 tablet after dinner + 2 tablets at bedtime
  • Day 2: 1 tablet before breakfast + 1 tablet after lunch + 1 tablet after dinner + 2 tablets at bedtime
  • Day 3: 1 tablet before breakfast + 1 tablet after lunch + 1 tablet after dinner + 1 tablet at bedtime
  • Day 4: 1 tablet before breakfast + 1 tablet after lunch + 1 tablet at bedtime
  • Day 5: 1 tablet before breakfast + 1 tablet at bedtime
  • Day 6: 1 tablet before breakfast
Alternate-day therapy (ADT): Alternate-day therapy is a corticosteroid dosing regimen in which twice the usual daily dose of corticoid is administered every other morning. The purpose of this mode of therapy is to provide the patient requiring long-term pharmacologic dose treatment with the beneficial effects of corticoids, white minimizing certain undesirable effects, including pituitary-adrenal suppression, Cushingoid stats, Corficoid withdrawal symptoms, and growth suppression in children.

The following should be kept in mind when considering alternate-day therapy:
  • Basic principles and indications for corticosteroid therapy should be applied.
  • Alternate-day therapy is a therapeutic technique primarily designed for pefienis in whom long-term pharmacologic corticoid therapy is anticipated.
  • In less severe disease processes in which corticoid therapy is indicated, it may be possible to initiate treatment with alternate-day therapy. More severe disease state usually will require daily divided high dose therapy for initiai control of the disease process. The initial suppressive dose level should be continued until a satisfactory clinical response is obtained, usually four to ten days in the case of many allergic and collagen diseases.

Interaction

Erythromycin, Clarithromycin, Phenobarbital, Phenytoin, Rifampin and Ketoconazole inhibit the metabolism of Methylprednisolone. Estrogens, including With control pills, can increase the effect of corticosteroids by 50%. Cyclosporin reduces the metabolism of Methylprednisolone. while Methylprednisolone reduces the metabolism of Cyclosporin. Methylprednisolone may increase or decrease the effect of blood thinners (e.g. Warfarin). For all these Interactions, the dose of Methylprednisolone may need to be lowered.

Contraindications

Systemic fungal infections arid known hypersensitivity to components.

Side Effects

Short courses of Methylprednisolone are usually well-tolerated with few, mild side effects. Long term, high doses of Methyiprednisoione may produce predictable and potentially serious side effects. Whenever possible, the lowest effective doses of Methylprednisolone should be used for the shortest length of time to minimize side effects. Alternate day dosing also can help reduce side effects. Side effects of Methylprednisolone and other corticosteroids range from mild annoyances to serious irreversible bodily damage. Side effects include fluid retention, weight gain, high blood pressure, potassium loss, headache, muscle weakness, hair growth on the face, glaucoma, cataracts, peptic ulceration, growth retardation in children, convulsions, and psychic disturbances including depression, euphoria, insomnia etc. Prolonged use of Methylprednisolone can depress the ability of the body's adrenal glands to produce corticosteroids. Abruptly stopping Methylprednisolone in these individuals can cause symptoms of corticosteroid insufficiency, with accompanying nausea, vomiting, and even shock. Therefore, withdrawal of Methylprednisolone usually is accomplished by gradually lowering the dose. Gradually tapering Methylprednisolone not only minimizes the symptoms of corticosteroid insufficiency, it also reduces the risk of an abrupt flare of the disease being treated.

Pregnancy & Lactation

Pregnancy category C. Dregs should be given only if the potential benefit justifies the potential risk te the foetus. Mefhyiprednisofone has not been adequately evaluated in nursing mothers.

Precautions & Warnings

Adrenocortical insufficiency may persist for months after discontinuation of therapy; therefore, in any situation of stress occurring during that period, hormone therapy should be reinstituted. Since mineralocorticoid secretion may be impaired, salt and/or a mineralocorticoid should be administered concurrently. There is an enhanced effect of corticosteroids on patients with hypothyroidism and in those with cirrhosis. Corticosteroids should be used cautiously in patients with ocular herpes simplex because of possible corneal perforation. Aspirin should be used cautiously in conjunction with corticosteroids in hypoprothrombinemia. The growth and development of infants and children on prolonged corticosteroid therapy should be carefully observed.

Overdose Effects

Report of acute toxicity and/or death following an overdose of glucocorticoid ere rare. No specific antidote is available; treatment is supportive and symptomatic. Serum electrolytes should be monitored.

Storage Conditions

Store in a cool and dry place, away from light. Keep out of reach of children.

Alternative brands of Methyl Prednisolone

Other brands with the same generic name, cheapest first.

See all 22 brands

Medicine information is for reference only and is not medical advice. Always follow your doctor's prescription and check with a pharmacist.